DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neumega (Oprelvekin) - Intervertebral Disc Protrusion - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Intervertebral Disc Protrusion (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neumega (Oprelvekin) where reactions include intervertebral disc protrusion. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Neumega side effects in male

Reported by a consumer/non-health professional from United States on 2011-10-17

Patient: male, weighing 87.1 kg (191.6 pounds)

Reactions: Intervertebral Disc Protrusion, Weight Decreased, Pain, Hypoaesthesia, Burning Sensation, Body Height Increased, Weight Increased, Overdose, Malaise, Pulse Absent, Thyroid Disorder, Feeling Abnormal, Muscle Spasms

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2002-02-15
    End date: 2003-03-01

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2002-02-15
    End date: 2003-03-01

Neumega
    Dosage: unk
    Indication: Pain
    Start date: 2002-11-01
    End date: 2003-02-28

Neumega
    Dosage: unk
    Indication: Abdominal Pain Upper
    Start date: 2002-01-01
    End date: 2003-02-28

Other drugs received by patient: Interferon Alfa-2A



Possible Neumega side effects in male

Reported by a consumer/non-health professional from United States on 2011-10-04

Patient: male, weighing 88.0 kg (193.6 pounds)

Reactions: Intervertebral Disc Protrusion, Burning Sensation, Body Height Increased, Weight Increased, Overdose, Activities of Daily Living Impaired, Pain, Pulse Absent, Hypoaesthesia, Muscle Spasms

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2002-02-15
    End date: 2003-03-01

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2002-02-15
    End date: 2003-03-01

Neumega
    Dosage: unk
    Indication: Pain
    Start date: 2002-11-01
    End date: 2003-01-01

Other drugs received by patient: Interferon Alfa-2A

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017